Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients.

Aleksandra RymarzKatarzyna RomejkoAnna MatyjekZbigniew BartoszewiczStanisław Niemczyk

Published in: Nutrients (2021)

Our results suggest that OPG can be an independent marker of PEW, inflammation and vascular metabolic disturbances in patients with chronic kidney disease.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
oxidative stress
prognostic factors
risk factors
patient reported outcomes
nuclear factor
toll like receptor
inflammatory response